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Reconstructive
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Objective: Soft-tissue sarcomas are most frequently located deep within myofascial
compartments. Superficial soft-tissue sarcomas (S-STS) are relatively less common
and may be managed differently than deep sarcomas because generous resection
margins are often possible without sacrificing critical structures. We sought to investigate the frequency and types of soft-tissue reconstructive procedures that are
required following excision of S-STS.
Methods: We reviewed 457 consecutively treated patients with S-STS with a minimum
2-year follow-up from our prospectively maintained database between 1989 and 2009.
Results: Mean follow-up was 10.5 years (range, 2–23). Four hundred twenty-one tumors (91%) were excised with negative margins, 38 (8.3%) had microscopically positive margins, and three (0.7%) had grossly positive margins. One patient required an
amputation. In 271 (58%) patients, the wounds were closed primarily. In comparison, 93 patients (20%) required a rotation flap, 70 (15%) required a split-thickness
skin graft, and 23 (5%) underwent a free tissue transfer (ie, advanced reconstructive procedure). The overall complication rate was 12%, although 43% of patients
undergoing free tissue transfer developed complications (P = 0.04). An unplanned
excision before referral to our center was a risk factor for local recurrence (P = 0.03)
when residual tumor was recovered in the reexcision specimen pathologically.
Conclusions: Although concern about the morbidity associated with a free tissue
transfer (ie, advanced reconstructive procedure) may potentially limit the adequacy of resection in some patients with S-STS, the results of this study showed that
the majority of patients had complete excisions with negative margins and primary closure. Obtaining a negative margin when excising a known or suspected
S-STS rarely requires an advanced reconstructive procedure and almost never
results in loss of limb. (Plast Reconstr Surg Glob Open 2017;5:e1553; doi: 10.1097/
GOX.0000000000001553; Published online 13 November 2017.)

INTRODUCTION

Soft-tissue sarcomas are mesenchymal tumors that
occur most commonly in the extremities, but with a cumulative incidence of less than 1% per year.1 Although
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most extremity and truncal soft-tissue sarcomas are located deep within myofascial compartments, superficial
soft-tissue sarcomas (S-STS) are relatively less common
and differ from deep STS in several important ways.2–7 SSTS are frequently smaller3,4 than deep tumors, and as a
result are associated with lower rates of distant metastasis
and higher rates of disease-free survival (DFS).4,8 Resection of S-STS rarely involves critical structures, such as
major nerves and arteries, which are typically involved
with deeper tumors. However, due to their small size and
superficial location, these lesions may be not be recognized as malignant on initial presentation and are frequently treated by marginal or intralesional resection
before referral to a dedicated sarcoma center, a scenario
often referred to as an “unplanned excision.”9,10 In these
cases, resection margins are frequently positive necessitating further treatment.
Disclosure: The authors have no financial interest to
declare in relation to the content of this article. The Article
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Using the largest series of consecutively treated patients with S-STS to date, this study aims to investigate the
frequency and types of soft-tissue reconstructive procedures that are required following definitive resection of
S-STS. In this study, we also investigate relevant oncologic
outcomes.

METHODS AND MATERIALS
Patients and Treatment

Between January 1986 and December 2009, 1,295 consecutive patients with soft-tissue sarcoma of the trunk and
extremities were enrolled in the prospectively maintained
database. Among these patients, 457 (35%) underwent
surgical resection for a histologically proven S-STS of the
extremities or trunk. We defined S-STS as a malignant
mesenchymal neoplasm located exclusively superficial to
the fascia of the underlying muscular compartment. This
assessment was based on magnetic resonance imaging as
well as clinical assessment at the time of surgery. For instance, a patient assessed as having an S-STS preoperatively
but found to have fixation to or transgression through the
underlying fascia was not classified as having an S-STS. Patients with Kaposi’s sarcoma and atypical fibroxanthoma
were excluded. Malignant ulceration was defined as visible
ulceration or fungation of the tumor through the skin.
The surgical plan for each patient was made with priority given to performing a wide excision of the tumor
(or tumor bed in the case of patients undergoing revision
surgery). For patients in whom free tissue transfer was
expected (ie, advanced reconstructive procedure requiring a multidisciplinary surgical team), the plastic surgery
team was available to perform immediate reconstruction.
For patients in whom reconstruction was expected to be
performed by the orthopedic oncologist (eg, basic rotation flaps, skin grafts), the plastic surgery team was not
directly involved in the case. In all patients, the soft-tissue
reconstruction was performed during the same operation
as the resection.
Data Collection and Statistical Analysis

A retrospective patient review of a prospectively collected database was performed following Research Ethics
Board approval. Data collected included patient age and
gender, tumor size and location, tumor grade, treatment
before referral to the sarcoma center, local recurrence following prior treatment elsewhere, utilization of adjuvant
therapy, margins at definitive surgical resection (ie, closest
margin, closest radial margin), and disease status at diagnosis and final follow-up. The deep margin for all patients
in this study was fascia. The goal for margin of resection
was 2 cm, though margins were considered negative if they
demonstrated no signs of microscopically positive margins
at the time of resection. The type of soft-tissue reconstructive procedure required after definitive resection was categorized as primary wound closure, skin graft alone, local
rotation flap +/- skin graft, and free tissue transfer (ie,
advanced reconstructive procedure) +/- skin graft. For
patients who had undergone prior “unplanned excision”
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Table 1. Baseline Patient and Tumor Characteristics
Patient Characteristics

Mean (Range)/n (%)

Age at diagnosis (y)
Sex, N (%)
 Male
 Female
Unplanned excision before referral
 Subset with prior positive margin
 Subset with prior close but negative
margin
 Subset with residual tumor found on
reexcision
Tumor maximum diameter (cm)
Tumor location
 LE
 UE
Histological diagnosis and subtype
 Undifferentiated pleomorphic
sarcoma
 Leiomyosarcoma
 Myxoid/round cell liposarcoma
 Fibrosarcoma
 Malignant peripheral nerve sheath
tumor
 Other
Tumor grade
 Grade I
 Grade II
 Grade III
 Unknown
Malignant ulceration

P

55 (18–97)
251 (55)
206 (45)
346 (76)
281 (81)
65 (19)

0.554
0.446
0.867
0.133

151 (44)
4.6 (0.5–23.0)
292 (64)
165 (36)

0.586
0.306

178 (39)
91 (20)
36 (8)
29 (6)
22 (4)
101 (22)
87 (19)
142 (31)
224 (49)
4 (0.8)
46 (10)

0.195
0.31
0.495

before referral, we examined whether they had positive resection margins and whether there was residual tumor recovered in the reexcision specimen pathologically. Once
patients had been seen by a specialty sarcoma center, we
examined whether surgical margins were positive or negative and noted local recurrence, overall survival (OS), and
overall DFS. Finally, we determined which reconstructive
surgery, if any, patients required after completing their definitive surgical excision.
Patient, disease, and treatment-related variables for
patients with different types of soft-tissue reconstruction
were compared using Fisher’s exact test or the chi-square
test. Survival curves were calculated using the KaplanMeier method and survival differences were compared by
the log-rank test. To investigate for differences between
reconstructive type and disease variables (eg, tumor size),
the log rank test was applied. Logistic regression models
were also used to evaluate the effect of patient and tumor
characteristics on local recurrence and OS outcomes in
the form of hazard ratios; these ratios are factors that indicate the multiplicative factor of comparative risk between
2 groups.

RESULTS
Patients and Disease Characteristics

A total of 457 patients were identified in our database
that had STS-E with a mean follow-up of 10.5 years (range,
2–23 years). Baseline patient and tumor features are presented in Table 1. Mean patient age was 55 years (range,
18–97 years). Three hundred forty-six patients (76%)
had undergone an unplanned excision before referral to
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our institution; of these, resection margins were positive
in 281 patients (81%). Two hundred ninety-two tumors
(64%) were located on the lower extremity and 165 tumors (36%) were located on the upper extremity. Mean
tumor size was 4.6 cm (range, 0.5–23 cm). The most common histologies were undifferentiated pleomorphic sarcoma (n = 178; 39%), leiomyosarcoma (n = 91; 20%), and
myxoid liposarcoma (n = 36; 8%; Table 1). There were 87
grade I tumors (19%), 142 grade II tumors (31%), and
224 grade III tumors (49%). In 4 tumors, a grade was not
assigned. Malignant ulceration was present at the time of
surgery in 46 tumors (10%). There were no patients with
known metastatic disease at the time of surgery. There
were no statistically significant differences in patient and
tumor characteristics.
Treatment Modalities and Reconstructive Techniques

Definitive resection margins were negative in 421 patients (92%) and positive in 36 patients (8%; Table 2).
The majority of patients (n = 346; 76%) underwent wide
reexcision at our center following a prior unplanned resection performed elsewhere. One hundred ninety-seven
patients (43%) were treated with adjuvant or neoadjuvant
radiation therapy after referral to our institution, whereas
only 6 patients (1%) received adjuvant or neoadjuvant
chemotherapy. Two hundred seventy-one patients (58%)
underwent wide resection and primary wound closure.
Ninety-three patients (20%) underwent wide resection
and closure with a rotation flap and split-thickness skin
Table 2. Baseline Treatment Characteristics
Patient Characteristics
Resection type
 Primary wide resection
 Wide reexcision of the tumor bed
following prior unplanned resection
Overall margin status
 Negative
 Positive
Type of soft-tissue reconstruction
 Primary closure
 STSG
 Rotation flap
 Free flap
Radiation therapy
 No radiation therapy
 Preoperative radiation
 Postoperative radiation
 Preoperative radiation with postoperative boost
Chemotherapy
Follow-up, survival, and events
 Follow-up (y)
 OS time (mo)
DFS (mo)
% 5-Year metastasis (grade 1)
Free survival by tumor grade (%)
 Grade 2
 Grade 3
% 5-Year local recurrence (grade 1)
Free survival by tumor grade (%)
 Grade 2
 Grade 3
Disease following reexcision
 Positive for disease
 No disease

Mean (Range)/n (%)

P

111 (24)
346 (76)
421 (92)
36 (8)

0.924
0.076

271 (58)
70 (15)
93 (20)
23 (5)

0.598
0.144
0.215
0.053

260 (57)
127 (28)
60 (13)
10 (2)

0.571
0.284
0.131
0.014

6 (1)

0.012

10.5 (2–23)
71 (4–247)
65 (1–187)
96.10
89.30
78.50
99.20
92.80
91.00
151 (44)
196 (56)

graft (STSG). Seventy patients (15%) underwent wide resection and coverage with an STSG alone. Twenty-three
patients (5%) required a free tissue transfer for coverage
of the resected site.
Complications and Outcomes

Postoperative complications by reconstruction group
are listed in Table 3. Fifty-six patients (12%) had a complication directly related to surgery, and 19 (34%) of
them required reoperation. Patients undergoing free tissue transfer were the most likely to have a complication
(10/23; 43%; P = 0.04). In comparison, complications occurred in 16 of 93 patients (17%) treated with a rotation
flap and 10 of 70 (14%) who had an STSG alone. Only 20
of 271 patients (8%) treated with primary wound closure
developed a complication. However, this group included
2 patients with significant complications: One patient underwent resection of a posterior leg S-STS and, following
primary closure, developed compartment syndrome. She
was treated with fasciotomies and delayed wound closure.
Another patient had microscopically positive margins after resection of a distal leg S-STS and developed a wound
infection. She elected to have a transtibial amputation
rather than another attempt at limb-preserving resection
(which likely would have required a free tissue transfer) or
radiation therapy.
Mean OS was 71 months with a mean DFS of 65
months (Table 2). Five-year local recurrence-free survival
rates were greater than 90% for tumors of every grade
(Fig. 1A; P = 0.058). Five-year metastasis-free survival was
96.1%, 89.3%, and 78.5% for grades 1, 2, and 3, respectively (Fig. 1B; P < 0.001).
Patients who underwent an unplanned excision before
referral had an increased risk of local recurrence but only
when residual tumor was recovered pathologically from
reexcision specimen (P = 0.009; hazard ratio, 3.1). This
Table 3. Postoperative Complications Stratified by
Reconstruction Group
Soft Tissue
Reconstruction Group
Primary wound closure
(n = 271)

Complication
Type

Total
Number
Number Reoperated
(%)
(%)

20 (7)
Wound infection
11 (4.1)
Wound dehiscence
5 (1.8)
Wound seroma
2 (0.7)
Vascular
2 (0.7)
STSG (n = 70)
10 (14)
Infection
6 (8.6)
Vascular
1 (1.4)
Other
3 (4.3)
Rotation flap +/- STSG
16 (17)
(n = 93)
Infection
12 (13)
Dehiscence
4 (4)
Free tissue transfer +/10 (43)
STSG (n = 23)
Infection
7 (30)
Flap failure
1 (4)
Dehiscence
1 (4)
Seroma
1 (4)
Total
All types
56 (12)

8 (3)
5 (1.8)
1 (0.4)
0
2 (0.7)
3 (4)
2 (2.9)
1 (1.4)
0
4 (4.3)
4 (4.3)
0
4 (17)
3 (13)
1 (4)
0
0
19 (4)
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Fig. 1. Kaplan-Meier curves illustrating 5-year local recurrence-free survival (A) and 5-year metastasis-free survival according to grade
(B). A, With respect to local recurrence-free survival, patients with grades 1, 2, and 3 tumors had a survival rate of 99.2%, 92.8%, and 91%,
respectively (P = 0.058). B, With respect to metastasis-free survival, patients with grades 1, 2, and 3 tumors had a survival rate of 96.1%,
89.3%, and 78.5%, respectively (P < 0.001).

event occurred in 151 of 346 patients (44%) and was associated with a hazard ratio for local recurrence of 5.9 when
compared with those patients in whom tumor was not recovered upon reexcision. These patients were not more
likely to require an advanced reconstructive procedure or
to have a complication.

DISCUSSION

S-STS are underrepresented in the literature despite
having significantly different biology and clinical outcomes from their deep equivalents. An oft-cited reason for
inadequate margins obtained in the treatment of S-STS of
the extremities is the desire to avoid the need for soft-tissue reconstructive procedures.10 However, although wide
excision of S-STS may be viewed as undesirable from a
reconstructive and cosmetic perspective, multiple studies
have shown that obtaining an adequate resection margin
is a critical for local control and an independent predictor
of disease-free and metastasis-free survival.4–6,11 No data exist to describe what types of reconstructive procedures are
typically required or their frequency following excision of
S-STS of the extremities. Therefore, we performed a dedicated analysis of the largest series of consecutively treated
patients with S-STS of the extremities to determine the
utilization and complications associated with soft-tissue
reconstructive procedures.
We demonstrate that limb preservation can almost always be accomplished when treating patients with S-STS.
Only 1 patient in this series of 457 patients required an
amputation, despite an overall complication rate of 12%.
This paucity of amputations underlies an important difference between superficial and deep STS. Wound complications including infection and dehiscence following
treatment of patients for deep STS often result in compromise of skeletal, neurologic, or vascular structures that are
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critical for limb preservation. In comparison, patients with
S-STS may often require reoperation but rarely result in
loss of the limb following similar complications.
At our institution, orthopedic oncologists perform
STSGs and many rotation flaps. A separate plastic microsurgical reconstructive team performs more complex rotation flaps and all free tissue transfers. In the present study,
only 5% of patients required a free tissue transfer. The
majority of patients (58%) required only primary wound
closure, and another 35% required closures that could be
performed by an orthopedic oncologist. This was not due
to less aggressive resection techniques, as the surgical resection margins were negative in 92% of the patients in
this series.
In general, the complication rate increased with the
complexity of the reconstructive procedure required.
Free tissue transfer was associated with the highest rate of
complications (43%) and reoperation (13%), but there
were no failures of limb salvage in this treatment group.
There was free anterolateral thigh flap to the dorsal forearm that failed due to thrombosis. This flap was partially
debrided and the resulting wound healed by secondary
intention. Although the lowest rate of complications was,
not surprisingly, associated with primary wound closure,
this group of patients also encountered the 2 most severe
complications—1 patient required emergent fasciotomies
for compartment syndrome and another patient with
contaminated margins developed a severe infection that
ultimately required an amputation. Two patients initially
treated with primary closure required conversion to skin
grafts after wound dehiscence and open wound management. These were the only 2 patients who required conversion from one reconstructive type to another.
Recently, there has been increasing attention focused on
the effect of an unplanned sarcoma excision before referral
for definitive treatment.10,12–15 Unplanned excisions are of-
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ten the result of an understandable failure to identify a superficial mass as a sarcoma. The majority of patients in this
study (n = 346; 76%) were referred to our center secondary to unplanned surgical excisions performed elsewhere,
and most of them also had positive surgical margins (281;
81%), whereas a smaller group (65; 19%) had negative but
very close (eg, 1–2 mm) margins. In this series, having had
a prior unplanned excision did not predict the need for an
advanced reconstructive procedure. It also did not generally affect oncologic outcomes although those patients in
whom tumor was identified pathologically in the reexcision
specimen were at higher risk to develop a local recurrence
(P = 0.005). We would consider offering adjuvant radiation
therapy to such patients depending on the status of their final resection margins. However, the use of radiation therapy may significantly impact reconstructive decision making
and is well known to affect wound healing.16,17
The demographic characteristics of patients with S-STS
in this series have several differences compared with other
reports of extremity S-STS. In the present series, 68% of
tumors were smaller than 5 cm in maximum diameter. Although the relative prevalence of small (ie, less than 5 cm)
tumors in this series may have influenced the low rate of
advanced reconstructive procedures, it should be noted
that other series of S-STS had an even greater proportion
of small tumors. Cany et al.5 reported that 92% of S-STS
in their series of 105 patients were smaller than 5 cm, and
Salas et al.7 reported that 76% of S-STS in their series of
367 patients were under 5 cm.
Using the largest reported series of consecutively treated patients with S-STS, we demonstrate that completely
resected S-STS rarely require advanced reconstructive procedures. The importance of proper surgical planning and
management for patients with S-STS, with an emphasis on
wide negative margin excision, cannot be understated.
Concerns about the need for using free soft-tissue transfers (ie, advanced reconstructive procedures) should not
be a factor in limiting surgical margins or otherwise compromising a complete excision. Although advanced reconstructive techniques, when required, carry a high rate of
complications, this does not compromise the likelihood of
limb salvage. The biggest dilemma in dealing with S-STS
remains the high proportion of patients who continue to
be treated initially in the community as benign lesions and
are only referred to specialty sarcoma centers following incomplete resections. This will only be improved through
development and dissemination of management guidelines to facilitate early referral of a greater proportion of
patients with superficial masses who actually have S-STS.18
William C. Eward
Duke University Medical Center
Box 3312 DUMC
Durham, NC 27710
E-mail: w.eward@alumni.duke.edu
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